BSMV-based miR3134a silencing using <i>AtISP1</i>-based miRNA target mimicry in wheat. by Jian Jiao (364961)

Subjects:

BSMV-based miR159a silencing using the STTM approach in wheat. by Jian Jiao (364961)

Subjects:

BSMV-based miR159a silencing using <i>AtISP1</i>-based miRNA target mimicry in wheat. by Jian Jiao (364961)

Subjects:

<i>Barley Stripe Mosaic Virus</i> (BSMV) Induced MicroRNA Silencing in Common Wheat (<i>Triticum aestivum L</i>.) by Jian Jiao (364961)

Subjects:

Simultaneous silencing of miR159a and miR3134a using the BSMV expressing STTM approach in wheat. by Jian Jiao (364961)

Subjects:

Schematic diagram of integrating BSMV-γb vector and <i>AtIPS1</i>-based MIM or STTM sequences. by Jian Jiao (364961)

Subjects:

BSMV-based miR3134a silencing using the STTM approach in wheat. by Jian Jiao (364961)

Subjects:

Table_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Image_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif by Xiao-yang Gong (13103400)

“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Table_4_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Table_3_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”

Impact of combined induction of XBP1s and ATF6 on mutational tolerance varies across Env structural elements. by Jimin Yoon (9646685)

Subjects:

Sequence logo plots reveal diffsel across Env upon co-induction of XBP1s and ATF6. by Jimin Yoon (9646685)

Subjects:

Netrin-1 overexpression increases HCV RNA and specific infectivity of HCV virions in vitro whereas Netrin-1 depletion decreases HCV RNA and specific infectivity in vitro. by Marie-Laure Plissonnier (337713)

“…<p><b>A.</b> Detection of VR1-HA and Netrin-1-HA in transfected Huh7.5 cells by immunoblotting with the anti-HA antibody. …”

Oxytocin decreases locally evoked CeA GABAergic signaling and blunts alcohol effects. by Brendan J. Tunstall (6593357)

“…<p>(A) Representative eIPSPs recorded from CeA neurons of nondependent (upper) and dependent (lower) rats before (baseline) and during acute application of oxytocin (500 nM), oxytocin with alcohol (44 mM), and alcohol alone. …”

A visual comparison of the associated resistance data from Table 1 with the values of <i>k</i>_cat, <i>K</i>_M, catalytic efficiency (<i>k</i>_cat/<i>... by J. Roadnight Sheehan (20141887)

miR-135a regulates mRNA expression in ERRα-dependent and–independent manners. by Violaine Tribollet (237332)

Subjects:

miR-135a acts on ERRα mRNA expression via its 3’UTR. by Violaine Tribollet (237332)

Subjects:

miR-135a reduces the expression of ERRα. by Violaine Tribollet (237332)

Subjects: